Generic Drugs Market: Current Analysis and Forecast (2021-2027)

$4999$8699

Emphasis on Type (Simple, Super, Biosimilar); Application (Neurological Diseases, Cardiological Diseases, Metabolic Diseases, Infectious Diseases, Orthopedic Diseases, Genitourinary/Hormonal Diseases, Respiratory Diseases, and Others); Distribution Channel (Offline and Online); Region/Country (North America (US, Canada, Mexico, Rest of North America); Europe (UK, Germany, France, Italy, Spain,  Rest of Europe); Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific); and Rest of World)

Detailed Analysis of COVID-19 Impact on the Generic Drugs Market

Pages:

352

Table:

102

Figure:

183

Report ID:

UMHE21922

Geography:

Clear
  Get a Free Sample
SKU: UMHE21922 Categories: ,
Report Description
Table of content
Research Methodology

Report Description

Generic Drugs market
Generic Drugs market

REQUEST FREE SAMPLE PDF

The Generic Drugs market is predicted to grow at a CAGR of ~7% between 2021 and 2027. Key factors influencing the growth of the generic drugs market are the increasing prevalence of diseases around the world, strong healthcare infrastructure in developed economies, and increased awareness about different available medications around the world. The increasing prevalence of chronic and infectious diseases and the growing geriatric population in most countries coupled with rising intravenous generic product launches are further expected to drive the growth of the market during the forecast period. For instance, in July 2021, Generic Ferumoxytol, an injectable drug used to treat iron deficiency anemia (IDA), was launched in the U.S. by Sandoz. The rise in product launches of injectable generic products in developed countries is further expected to drive market growth. In addition, according to the National Health Interview Survey (NHIS) ~51.8 % of adults have a minimum of one chronic disease and 27.2 % of adults have several chronic diseases. Furthermore, according to the World Health Organization (WHO), the demand for generic medicines increased because of the prevalence of chronic diseases, propelling the generic drugs industry to new heights.

Some of the major players operating in the market include Cipla Ltd., Pfizer Inc., Fresenius Medical Care AG & Co. KGaA, Aurobindo Pharma Limited, Amneal Pharmaceuticals Inc., Alkem Laboratories Limited, Teva Pharmaceutical Industries Limited, Mylan N.V., Lupin Limited, and Sanofi S.A.

Insights Presented in the Report

“Amongst Type, biosimilar category to witness higher incremental gain during the forecast period”

Based on type, the generic drugs market is segmented into simple generic, super generic, biosimilar, and others in 2020, biosimilar drugs had a dominating share in the market. This is mainly due to the presence of a well-established infrastructure for chemical-based drugs and the increasing prevalence of chronic diseases across the world. In addition, the increasing demand for the more targeted and patient-specific drugs along with increasing investment in generic medicines because of low cost and greater opportunities in the developing nations like India and China is further expected to drive the market.

REQUEST FOR CUSTOMIZATION

Amongst Application, cardiovascular diseases category held a significant share in 2020”

Based on application, the market is bifurcated into neurological diseases, cardiological diseases, metabolic diseases, infectious diseases, orthopedic diseases, genitourinary/hormonal diseases, respiratory diseases, and others. Among these, cardiovascular is expected to witness significant growth in the forecast period. This is mainly due to the rising number of patients suffering from CVDs. For instance, in the U.S., about 18 million adults aged 20 and older have coronary artery disease (CAD). Furthermore, according to American Heart Association (AHA), coronary heart diseases cause 1 in every 7 deaths in the U.S., resulting in about 366,800 deaths each year. In addition, in 2020, there were 2.2 million new cases of lung cancer reported.

Amongst Distribution Channel, online to witness higher incremental gain during the forecast period”

Based on distribution channel, the market is bifurcated into offline and online. The online segment is expected to witness significant CAGR owing to the growing penetration of e-pharmacy platforms across the world coupled with increasing awareness regarding services offered by e-pharmacy. Furthermore, the growing focus on digitization and rising internet penetration in developing nations are some other key factors driving the market.

“APAC is expected to be the Fastest-Growing Region in Global Generic Drugs Market During 2021–2027F”

For a better understanding of the market, the report is analyzed based on different regions including North America (US, Canada, Mexico, Rest of North America); Europe (UK, Germany, France, Italy, Spain, Rest of Europe); Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific); and Rest of World. In 2020, APAC dominated the market on account of the rising research and development initiatives and the presence of a large number of pharmaceutical companies in countries such as India and China of the region. For instance, as per the India Brand Equity Foundation, India is the largest provider of generic drugs globally. Indian pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the U.S., and 25% of all medicine in the U.K.

SPEAK TO ANALYST

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry


Customization Options:

The Generic Drugs market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Limitation
1.3.Stakeholders
1.4.Currency used in Report
2.1.Research Process of the Generic Drugs Market
2.2.Research Methodology of the Generic Drugs Market
2.3.Forecasting Method 
2.4.Respondent Profile 
2.5.Main Objective of the Generic Drugs Market Study
3MARKET SYNOPSIS
4EXECUTIVE SUMMARY
5GENERIC DRUGS MARKET COVID-19 IMPACT
6GENERIC DRUGS MARKET REVENUE, 2019-2027F
7.1.Simple 
7.2.Super 
7.3.Biosimilar
8.1.Neurological Diseases
8.2.Cardiological Diseases
8.3.Metabolic Diseases
8.4.Infectious Diseases
8.5.Orthopedic Diseases
8.6.Genitourinary/Hormonal Diseases
8.7.Respiratory Diseases
8.8.Others 
10.1.North America  
 10.1.1.U.S. 
 10.1.2.Canada 
 10.1.3.Rest of America
10.2.Europe   
 10.2.1.U.K. 
 10.2.2.Germany 
 10.2.3.France 
 10.2.4.Italy 
 10.2.5.Spain 
 10.2.6.Rest of Europe
10.3.Asia-Pacific  
 10.3.1.China 
 10.3.2.India 
 10.3.3.Japan 
 10.3.4.Rest of Asia-Pacific
10.4.Rest of the World  
11.1.Market Drivers
11.2.Market Challenges
11.3.Impact Analysis
12GENERIC DRUGS MARKET OPPORTUNITIES
13GENERIC DRUGS MARKET TRENDS
14LEGAL & REGULATORY FRAMEWORK
15.1.Demand Side Analysis
15.2.Supply Side Analysis
16VALUE CHAIN ANALYSIS
17.1.Competitive Landscape
 17.1.1.Porter’s Five Forces Analysis
18.1.Cipla Ltd. 
18.2.Pfizer Inc. 
18.3.Fresenius Medical Care AG & Co. KGaA
18.4.Aurobindo Pharma Limited
18.5.Amneal Pharmaceuticals Inc.
18.6.Alkem Laboratories Limited
18.7.Teva Pharmaceutical Industries Limited
18.8.Mylan N.V.
18.9.Lupin Limited
18.10.Sanofi S.A.
19DISCLAIMER

Research Methodology

Research Methodology for the Generic Drugs Market Analysis (2021-2027)

Analyzing the historical market, estimating of the current market, and forecasting the future market of the generic drugs market were the three major steps undertaken to create and analyze the adoption of generic drugs in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the generic drugs market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Seek More Details About Research Methodology

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the generic drugs through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the generic drugs market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report are type, application, and distribution channel. Further country-level analyses were conducted to evaluate the overall adoption of generic drugs in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of generic drugs. Further, we conducted factor analysis using dependent and independent variables such as the increasing digitalization of industries and urbanization in developing countries. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the generic drugs sector across the globe.

REQUEST FREE SAMPLE PDF

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the generic drugs market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (US$) and the adoption rate of generic drugs across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the generic drugs market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market


Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Generic Drugs market
Generic Drugs market

SPEAK TO ANALYST

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the generic drugs market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of type, application, distribution channel, and regions of the generic drugs market.

The main objective of the Generic Drugs Market Study

The current & future market trends of generic drugs were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of generic drugs in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of type, application, distribution channel, and regions.
  • Define and analysis of the regulatory framework for the Generic Drugs industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the generic drugs market for the major region
  • Major regions studied in the report include North America (US, Canada, Mexico, Rest of North America); Europe (UK, Germany, France, Italy, Spain, Rest of Europe); Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific); and Rest of World.
  • Company profiles of the generic drugs market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?